Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.
Janssen Research & Development, LLC
Varian, a Siemens Healthineers Company
Verastem, Inc.
Boehringer Ingelheim
Bayer
AstraZeneca
Pilatus Biosciences Inc
GlaxoSmithKline
Pfizer
DualityBio Inc.
Shanghai Juncell Therapeutics
GlaxoSmithKline
IDRx Inc. - A GSK Company
Revolution Medicines, Inc.
Revolution Medicines, Inc.
RefleXion Medical
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Mirai Medical
Binhui Biopharmaceutical Co., Ltd.
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd